Therefore, cDNA microarrayanalysis, high-throughput sequencing technologies, on-line databases analysis,biochemistry, and molecular biology were applied to evaluate PNO1 as a prognosticbiomarker and its underlying molecular mechanisms of glioma development. Here, PNO1 is linked to central nervous system cancer.